Specialized Medical Company · TADAWUL:4019
Specialized Medical — Q1 2026 Earnings Presentation
32 slides from Specialized Medical's earnings presentation, May 12, 2026
Slide 1: Specialized Medical Company (SMC Healthcare) Q1 2026 Results Presentation
Specialized Medical Company (SMC Healthcare) Q1 2026 |Results Presentation May 12, 2026
Slide 2: Disclaimer
Disclaimer This presentation contains statements that are, or may be deemed to be, forward looking statements, including statements about the beliefs and expectations of Specialized Medical Company (SMC Healthcare or SMC) (the "Company") . These statements are based on the Company’s current plans, e
Slide 3: Today's Presenters
Today’s Presenters Bassam Chahine Mr. Hani Charani Mr. Faisal Altimyat Chief Executive Officer Chief Financial Officer Director of Investor Relations • 30 Years of Experience • 34 Years of Experience • 11 Years of Experience • 25 Years at SMC • 21 Years at SMC • 1 Year at SMC Q1 2026 | Results Prese
Slide 4: Table of Contents
Table of Contents Company Overview 1 & Strategic Updates 2 Q1 2026 Performance 3 Outlook 4 Q&A 5 Appendix Q1 2026 | Results Presentation 4
Slide 5: Company Overview & Strategic Updates
Company Overview & Strategic Updates
Slide 6: SMC Healthcare is a Leading Integrated Healthcare Provider
SMC Healthcare is a Leading Integrated Healthcare Provider with Comprehensive Services Covering the Entire Healthcare Value Chain SMC Healthcare operates two hospitals and one polyclinic, with more than 330 clinics, a range of ancillary services, including home healthcare, diagnostics and patient su
Slide 7: Medical Services Overview
Medical Services Overview SMC continues to prioritize outpatient and higher -margin acute services, with the transition completed following the repositioning of capacity previously allocated to LTC in 2024 and 2025 . In Q 1 2026 , the Company continued to scale Strategic shift its outpatient platfor
Slide 8: Key Highlights – Q1 2026
Key Highlights – Q1 2026 Net Revenue Strong Profitability Launch of SMC Improved Balance Sheet Growth Sustained Expansion Clinics in Al Malqa Utilization Strengthening Driven by continued Supported by improved 14 clinics operational and Inpatient and outpatient Net Debt/EBITDA 3 outpatient capacity
Slide 9: Advancing Current Operations and Upcoming Expansions
Advancing Current Operations and Upcoming Expansions Launch of SMC Clinics SABIC PPP Update Location Clinic Number of Timeline Operation of a 150 -bed MOH mental hospital under PPP Al Malqa Capacity operational The remaining (SABIC Behavioral Care Specialist Hospital) District , clinics clinics will
Slide 10: Upcoming Expansions SMC 3 & SMC 4 Progress
Upcoming Expansions SMC 3 & SMC 4 Progress SMC 3 and SMC 4 Progress SMC 3 (Northern Ring Road) SMC 4 (Al Khuzam Suburb) Foundation and early construction activities progressed during Q 1 2026 , supporting During Q 1 2026 , approximately 80 % of the design phase was continued development of the proje
Slide 11: Core Growth Strategy Centered around Northern Riyadh
Core Growth Strategy Centered around the Expanding Northern Riyadh Region with Three New Hospitals and One Polyclinic Long Term New Healthcare Facilities (est. $ 3+ bn in CAPEX) to be Financed through a Combination of Debt and Strategy Internal Cash Flows 2026 2028 2028 2029 SMC Clinics (Launched) S
Slide 12: Clinical and Academic Achievements
Clinical and Academic Achievements Successfully renewed the Organ donation Legacy relationship with institutional accreditation with the Saudi Center for Alfaisal University for the National Excellence Organ Transplantation spanning 10 years with In Health Training for the (SCOT) which saved 4 SMC h
Slide 13: Awards and Achievements
Awards and Achievements Achieved 2026 World’s Best Hospitals Listing (by statista ) Achieved 2026 Best Specialized Hospitals Middle East Listing (by statista ) January 24 th , Received 2 awards from UK -based Global Brands Magazine 2026: 2026: Hosted 1. “Best Healthcare Branding Transformation” “Lea
Slide 14: Q1 2026 Performance
Q1 2026 Performance
Slide 15: Outpatient and Acute Care Growth Driving Q1 2026 Performance
Outpatient and Acute Care Growth Driving Q1 2026 Performance Completed Shift Toward High -Performing Acute Specialties and Continued Outpatient Expansion Gaining Strong Momentum Successful transition Inpatient Revenue Growth New Clinics Delivering Solid Results Toward higher -margin acute services N
Slide 16: Realized Operational Shift and Continued Outpatient Ramp-Up
Realized Operational Shift and Continued Outpatient Ramp -Up Driving Q1 2026 Performance • +3.3% YoY net revenue growth $ million Q1 2026 Q1 2025 Variance (YoY) (unless stated otherwise) • Driven by utilization improvement and shift to higher -margin acute services Net revenue • Growth achieved desp
Slide 17: Resilient Q1 2026 Performance despite Seasonal Impact
Resilient Q1 2026 Performance despite Seasonal Impact Q1 25 vs Q1 26 Q4 25 vs Q1 26 +3.3% -6.4% Revenue moderation Net due to seasonality Revenue • Net revenue decline -6.4% QoQ 368.4 380.7 406.9 380.7 ($ mn ) • Reflects current operating environment Q1 25 Q1 26 Q4 25 Q1 26 • Seasonal factors (Ramad
Slide 18: Strengthened Balance Sheet and Improved Liquidity
Strengthened Balance Sheet and Improved Liquidity 1.7x Net Debt / EBITDA 53% Debt / Equity 0.9x YoY 20.9pp YoY 107 Receivables Days 102.1* Payables Days vs 95.4 days in Q1 vs 93.2* days in Q1 2025 2025 Q1 2026 Highlights • Leverage • Outstanding debt • Receivables days • Payables days • Capital expe
Slide 19: Outlook
smc 3k SMC Healthcare Sar Alesl gus pl yl Outlook
Slide 20: FY 2026 Guidance
FY 2026 Guidance SMC ’s 2026 outlook (pre -March) following strong financial results and sustained strategic execution in a transitional year. FY 2025 Actual FY 2026 Guidance (Pre -March 2026) Results Operations Financials (excluding $60.6 million one -off gain) 581 $ 1.6 bn - 1.7 bn c. 23% - 25% $
Slide 21: Thank You
Thank You
Slide 22: Q&A
smc 3 SMC Healthoare Gar Alesl gus pl yl Q&SA
Slide 23: Appendix
Appendix
Slide 24: Creating Value for Shareholders
Creating Value for Shareholders $ 80M Cash dividend $ 0.32 Dividend per share Shareholder Returns and Dividend Distribution SMC Board of Directors A $ 200 million special one -time Leverage expected to remain below recommended the distribution of an cash dividend was approved and long -term guidance
Slide 25: SMC at a Glance – As of Q1 2026
SMC at a Glance – A s of Q1 2026 2 1 586 337 Hospitals Polyclinic Inpatient Beds Outpatient Clinics $ 380.7 mn $ 69.3 mn $ 32.5 mn Net Revenue 1 EBITDA Net Profit Accreditations 1: Calculated as gross revenue minus contractual obligations & NPHIES Q1 2026 | Results Presentation 25
Slide 26: Two Decades of Growth: Regional Healthcare Powerhouse
Through Two Decades of Growth, SMC Has Emerged as a Regional Healthcare Powerhouse Establishment Strengthening Existing Footprint Expansion Phase 1999 2002 2004 2005 2006 2012 2014 2020 2024 2025 2026 → Launch of Expansion of Expansion of Agreement Developed Developed Further Launch of Further Compl
Slide 27: SMC 1 is Our Inaugural Hospital
SMC 1 is Our Inaugural Hospital, Centrally Located In Riyadh, and Serving as Our Hub s ince 1999 Key Stats +26 Years Q1 2026 King Fahad Road 206.2K Clinic patients Established Facilities Capacity 1999 72,788 sqm on • 191 Beds • 9 Delivery 24.8K 9,579 sqm of land • 116 Clinics rooms Emergency cases S
Slide 28: SMC 2 Launched in 2020
SMC Expanded Capacity with the Launch of Our Second Hospital in 2020, Delivering Enhanced Efficiency and Patient Experience Key Stats +5 Years Q1 2026 King Fahad Road 134.8K Clinic patients Established Facilities Capacity 2020 72,788 sqm on • 191 Beds • 9 Delivery 33.6K 9,579 sqm of land • 116 Clini
Slide 29: Proven Track Record with Consistent Growth and Profitability
SMC Has a Proven Track Record of Delivering Exceptional Healthcare with Consistent Growth and Profitability 159% 95% 183% IP Beds - Acute OP Clinics Patient Visits 192 497 166 323 554K 1,567K 2019 FY 2025 2019 FY 2025 2019 FY 2025 $ 1.54 bn Net Revenue CAGR $ 266 mn Net Revenue: 11.7% Net Profit $ 2
Slide 30: Key Investment Highlights
Key Investment Highlights Robust Macro Strong Roots in Riyadh Comprehensive Environment and Driving Unmatched Services Covering the Favorable Demographics Accessibility and Entire Healthcare Value Supported by KSA’s Vision Cementing Market Chain 2030 Position Team of Top -Tier Long -Serving and Cons
Slide 31: Scaling a Resilient Healthcare Platform
Scaling a Resilient Healthcare Platform by Digitizing the Core, Lifting Margins, Adding Capacity and Monetizing Adjacencies STRATEGIC Operational excellence & Outpatient clinics growth & margin Expand Riyadh Diversified growth PILLAR digital reach optimization via service -mix hospital cluster adjac
Slide 32: Riyadh Is the Backbone of KSA's Healthcare Infrastructure
Riyadh Is the Backbone of KSA’s Healthcare Infrastructure 1 and Inpatient Despite Ongoing Expansion, Riyadh’s Private Sector Outpatient Largest Share of the Population in KSA Hospital Bed Shortage Is Projected to Widen Activity Outpacing Public Sector Growth (1) as Demand Outpaces Supply # of Outpat
Specialized Medical Company (SMC Healthcare) — Q1 2026 Earnings Presentation on 6ix